Anthrax Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Anthrax Pipeline Drugs Market Overview
Anthrax pipeline drugs market research report provides comprehensive information on the therapeutics under development for Anthrax, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects.
Key Targets in the Anthrax Pipeline Drugs Market
The key targets in the anthrax pipeline drugs market are Anthrax Protective Antigen, Anthrax Lethal Factor Endopeptidase, 16S Ribosomal RNA, Anthrax Toxin, Anthrax Toxin Receptor 1, Anthrax Toxin Receptor 2, Bacterial Cell Wall, Cell Membrane, DNA Polymerase III, and Furin. Anthrax Protective Antigen has the highest number of pipeline products.
Anthrax Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the Anthrax Pipeline Market
The key MoA in the anthrax pipeline market are Anthrax Lethal Factor Endopeptidase Inhibitor, Anthrax Protective Antigen Inhibitor, 16S Ribosomal RNA Inhibitor, Anthrax Toxin Inhibitor, Anthrax Toxin Receptor 1 Inhibitor, Anthrax Toxin Receptor 2 Inhibitor, Bacterial Cell Wall Disruptor, Cell Membrane Disruptor, DNA Polymerase III Inhibitor, and Furin Inhibitor. Anthrax Lethal Factor Endopeptidase Inhibitor has the highest number of pipeline products.
Anthrax Pipeline Market, by MoA
For more MoA insights, download a free report sample
Key RoA in the Anthrax Pipeline Drugs Market
The key RoA in the anthrax pipeline drugs market are intravenous, oral, inhalational, intramuscular, intratumor, nasal, subcutaneous, and topical. Intravenous has the highest number of pipeline products.
Anthrax Pipeline Drugs Market, by RoA
For more RoA insights, download a free report sample
Key Molecule Types in the Anthrax Pipeline Market
The key molecule types in the anthrax pipeline market are small molecule, subunit vaccine, monoclonal antibody, antibody, antisense RNAI oligonucleotide, conjugate vaccine, live attenuated vaccine, oligonucleotide, peptide, and protein. Small molecule has the highest number of pipeline products.
Anthrax Pipeline Market, by Molecule Type
For more molecule type insights, download a free report sample
Key Companies in the Anthrax Pipeline Drugs Market
Key companies in the anthrax pipeline drugs market are Aphios Corp, Biologics Resources LLC, iBio Inc, BlueWillow Biologics Inc, China Biologic Products Holdings Inc, Crestone Inc, Dynavax Technologies Corp, and Emergent BioSolutions Inc. Aphios Corp has the highest number of pipeline products.
Anthrax Pipeline Drugs Market, by Companies
To know more about key companies in the anthrax pipeline market, download a free report sample
Market report overview
| Key targets | Anthrax Protective Antigen, Anthrax Lethal Factor Endopeptidase, 16S Ribosomal RNA, Anthrax Toxin, Anthrax Toxin Receptor 1, Anthrax Toxin Receptor 2, Bacterial Cell Wall, Cell Membrane, DNA Polymerase III, and Furin |
| Key MoA | Anthrax Lethal Factor Endopeptidase Inhibitor, Anthrax Protective Antigen Inhibitor, 16S Ribosomal RNA Inhibitor, Anthrax Toxin Inhibitor, Anthrax Toxin Receptor 1 Inhibitor, Anthrax Toxin Receptor 2 Inhibitor, Bacterial Cell Wall Disruptor, Cell Membrane Disruptor, DNA Polymerase III Inhibitor, and Furin Inhibitor |
| Key RoA | Intravenous, Oral, Inhalational, Intramuscular, Intratumor, Nasal, Subcutaneous, and Topical |
| Key molecule type | Small Molecule, Subunit Vaccine, Monoclonal Antibody, Antibody, Antisense RNAI Oligonucleotide, Conjugate Vaccine, Live Attenuated Vaccine, Oligonucleotide, Peptide, and Protein |
| Key companies | Aphios Corp, Biologics Resources LLC, iBio Inc, BlueWillow Biologics Inc, China Biologic Products Holdings Inc, Crestone Inc, Dynavax Technologies Corp, and Emergent BioSolutions Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Anthrax (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Anthrax (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Anthrax (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Anthrax (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Anthrax (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Anthrax (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Anthrax (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Biologics Resources LLC
BlueWillow Biologics Inc
China Biologic Products Holdings Inc
Crestone Inc
Dynavax Technologies Corp
Emergent BioSolutions Inc
GC Pharma
Greffex Inc
Hawaii Biotech Inc
iBio Inc
Innovative Biologics Inc
Integrated BioTherapeutics Inc
iNtRON Biotechnology Inc
NovoBiotic Pharmaceuticals LLC
Opal Biosciences Ltd
Paratek Pharmaceuticals Inc
Protein Potential LLC
ProThera Biologics Inc
Soligenix Inc
Vast Therapeutics Inc
Venomyx Inc
VLP Biotech Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the anthrax pipeline market?
The key targets in the anthrax pipeline market are Anthrax Protective Antigen, Anthrax Lethal Factor Endopeptidase, 16S Ribosomal RNA, Anthrax Toxin, Anthrax Toxin Receptor 1, Anthrax Toxin Receptor 2, Bacterial Cell Wall, Cell Membrane, DNA Polymerase III, and Furin.
-
What are the key MoA in the anthrax pipeline market?
The key MoA in the anthrax pipeline market are Anthrax Lethal Factor Endopeptidase Inhibitor, Anthrax Protective Antigen Inhibitor, 16S Ribosomal RNA Inhibitor, Anthrax Toxin Inhibitor, Anthrax Toxin Receptor 1 Inhibitor, Anthrax Toxin Receptor 2 Inhibitor, Bacterial Cell Wall Disruptor, Cell Membrane Disruptor, DNA Polymerase III Inhibitor, and Furin Inhibitor.
-
What are the key RoA in the anthrax pipeline market?
The key RoA in the anthrax pipeline market are intravenous, oral, inhalational, intramuscular, intratumor, nasal, subcutaneous, and topical.
-
What are the key molecule types in the anthrax pipeline market?
The key molecule types in the anthrax pipeline market are small molecule, subunit vaccine, monoclonal antibody, antibody, antisense RNAI oligonucleotide, conjugate vaccine, live attenuated vaccine, oligonucleotide, peptide, and protein.
-
What are the key companies in the anthrax pipeline market?
The key companies in the anthrax pipeline market are Aphios Corp, Biologics Resources LLC, iBio Inc, BlueWillow Biologics Inc, China Biologic Products Holdings Inc, Crestone Inc, Dynavax Technologies Corp, and Emergent BioSolutions Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Infectious Disease reports